Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-17 Sale(A) |
2025-03-20 4:35 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
31,278 | $8.8224 | $275,947 | 155,512 (Direct) |
View |
| 2025-03-17 Sale |
2025-03-19 4:12 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
31,278 | $8.8224 | $275,947 | 155,512 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-17 4:30 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,322 | $7.225 | $103,476 | 96,790 (Direct) |
View |
| 2025-01-08 Sale |
2025-01-10 4:30 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,545 | $8.2182 | $119,534 | 111,112 (Direct) |
View |
| 2024-11-29 Sale |
2024-12-03 5:48 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,392 | $4.5556 | $92,898 | 125,657 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-19 08:31 am |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
14,851 | $6.4726 | $96,125 | 146,049 (Direct) |
View |
| 2024-07-11 Sale |
2024-07-15 08:36 am |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,330 | $5.9734 | $79,625 | 160,900 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:25 pm |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
13,358 | $1.8761 | $25,061 | 13,358 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Exercise(A) |
2025-03-20 4:35 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $0 | 155,512 (Direct) |
View |
| 2025-03-17 Exercise(A) |
2025-03-20 4:35 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $1.29 | 155,512 (Direct) |
View |
| 2025-03-17 Exercise |
2025-03-19 4:12 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
20,000 | $0 | 155,512 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:30 pm |
N/A 2035-02-12 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
65,000 | $0 | 65,000 (Direct) |
View |
| 2023-11-28 Tax Withholding |
2023-11-30 5:00 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
17,328 | $0.9 | 174,230 (Direct) |
View |
| 2023-11-26 Option Award |
2023-11-28 4:30 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
104,516 | $0 | 191,558 (Direct) |
View |
| 2023-04-28 Option Award |
2023-05-02 5:05 pm |
N/A 2033-04-28 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-11-28 Option Award |
2022-11-30 6:26 pm |
N/A N/A |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu See Remarks |
73,684 | $0 | 73,684 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 5:05 pm |
N/A 2032-04-14 |
Candel Therapeutics Inc. | CADL | Tyagarajan Seshu See Remarks |
120,000 | $0 | 120,000 (Direct) |
View |